BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 33403026)

  • 1. N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer.
    Wu Q; Xie X; Huang Y; Meng S; Li Y; Wang H; Hu Y
    J Cancer; 2021; 12(3):682-692. PubMed ID: 33403026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of N
    Lu Z; Ma Y; Li Q; Liu E; Jin M; Zhang L; Wei C
    Cell Stress Chaperones; 2019 Mar; 24(2):333-342. PubMed ID: 30701478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.
    Yuan Y; Du Y; Wang L; Liu X
    J Cancer; 2020; 11(12):3588-3595. PubMed ID: 32284755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic, progressive and prognostic performance of m
    Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
    Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
    [No Abstract]   [Full Text] [Related]  

  • 6. N6-methyladenosine RNA demethylase ALKBH5 is testis-specifically downregulated in hybrid male sterile dzo and is a target gene of bta-miR-200a.
    Chen H; Zhang J; Yan Y; Zhu C; Wang L; Fu S; Zuo F; Zhang GW
    Theriogenology; 2022 Jul; 187():51-57. PubMed ID: 35504087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
    Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
    Front Oncol; 2020; 10():718. PubMed ID: 32547941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
    Xu D; Shao J; Song H; Wang J
    Biomed Res Int; 2020; 2020():9502560. PubMed ID: 32596399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
    Wang S; Zou X; Chen Y; Cho WC; Zhou X
    Front Genet; 2020; 11():580036. PubMed ID: 33584787
    [No Abstract]   [Full Text] [Related]  

  • 10. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
    Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
    Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The essential roles of m
    Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the Correlation Between Regulatory Proteins of N
    Sun Y; Liu G; Li M; Wang L; He Z; Gu S
    Biol Trace Elem Res; 2023 May; 201(5):2294-2302. PubMed ID: 35794303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular significance of the RNA m
    Lothion-Roy J; Haigh DB; Harris AE; Metzler VM; Alsaleem M; Toss MS; Kariri Y; Ntekim A; Robinson BD; Khani F; Gudas LJ; Allegrucci C; James VH; Madhusudan S; Mather M; Emes RD; Archer N; Fray RG; Rakha E; Jeyapalan JN; Rutland CS; Mongan NP; Woodcock CL
    Front Genet; 2022; 13():1096071. PubMed ID: 36733939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
    Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
    Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations.
    Liyanage C; Fernando A; Chamberlain A; Moradi A; Batra J
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2BP3 is an essential N
    Xu X; Cui J; Wang H; Ma L; Zhang X; Guo W; Xue X; Wang Y; Qiu S; Tian X; Miao Y; Wu M; Yu Y; Xu Y; Wang J; Qiao Y
    Mater Today Bio; 2022 Dec; 17():100503. PubMed ID: 36457846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
    Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
    FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.